𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver transplantation for primary sclerosing cholangitis – a single-center experience

✍ Scribed by H. Lidén; J. Norrby; S. Friman; M. Olausson


Publisher
Springer
Year
2000
Tongue
English
Weight
44 KB
Volume
13
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pediatric liver transplantation for prim
✍ Tamir Miloh; Ravinder Anand; Wendy Yin; Miriam Vos; Nanda Kerkar; Estella Alonso 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views

Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease in children. The aim of this study was to determine the characteristics and outcomes of children with PSC who were listed for liver transplantation (LT). Children who underwent transplantation for PSC according to the Studies o

Recurrence of primary sclerosing cholang
✍ Ivo W. Graziadei; Russell H. Wiesner; Kenneth P. Batts; Paul J. Marotta; Nichola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been suggested; however, it has not been fully defined because of numerous complicating factors and the lack of diagnostic criteria. In the present study, we investigated the recurrence of PSC by developing strict

Biliary malignancies in primary sclerosi
✍ B Nashan; H J Schlitt; G Tusch; K J Oldhafer; B Ringe; S Wagner; R Pichlmayr 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

is suggested, and transplantation should be taken into Primary sclerosing cholangitis (PSC) is a chronic inconsideration at scores above 4. (HEPATOLOGY 1996; flammatory disease associated in 10% to 36% of those 23:1105-1111.) with hepatobiliary malignancies, which are, in the majority of cases, not

Risk factors for recurrence of primary s
✍ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f